Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Kamal

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
F1000 Biology Reports|October 16, 2010
Bitopic ligands: all-in-one orthosteric and allostericMaud Kamal, Ralf Jockers
Frontiers in Endocrinology|June 1, 2012
Biological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemMaud Kamal, Ralf Jockers
Neuroendocrinology|December 14, 2011
History and biological significance of GPCR heteromerization in the neuroendocrine systemKenjiro Tadagaki, Ralf Jockers, Maud Kamal
Trends in Pharmacological Sciences|July 1, 2011
Asymmetry of GPCR oligomers supports their functional relevancePascal Maurice, Maud Kamal, Ralf Jockers
Canadian Journal of Physiology and Pharmacology|July 22, 2017
Angiotensin II receptors' modulation of calcium homeostasis in human vascular endothelial cellsMaud Kamal, Danielle Jacques, Ghassan Bkaily
Current Opinion in Oncology|July 2, 2019
Molecular screening programs in different countries: what we learned and perspectivesEdith Borcoman, Christophe Le Tourneau, Maud Kamal
Nature Medicine|May 1, 2019
Molecular profiling in precision medicine oncologyChristophe Le Tourneau, Edith Borcoman, Maud Kamal
Pharmacogenomics|June 9, 2017
The SHIVA01 trial: what have we learned?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Medecine Sciences : M/S|January 21, 2022
[Starting to integrate artificial intelligence for treatment decisions in oncology]Christophe Le Tourneau, Ivan Bièche, Maud Kamal
Personalized Medicine|September 28, 2018
Precision medicine in oncology: what is it exactly and where are we?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
F1000 Biology Reports|October 16, 2010
Bitopic ligands: all-in-one orthosteric and allostericMaud Kamal, Ralf Jockers
Frontiers in Endocrinology|June 1, 2012
Biological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemMaud Kamal, Ralf Jockers
Neuroendocrinology|December 14, 2011
History and biological significance of GPCR heteromerization in the neuroendocrine systemKenjiro Tadagaki, Ralf Jockers, Maud Kamal
Trends in Pharmacological Sciences|July 1, 2011
Asymmetry of GPCR oligomers supports their functional relevancePascal Maurice, Maud Kamal, Ralf Jockers
Canadian Journal of Physiology and Pharmacology|July 22, 2017
Angiotensin II receptors' modulation of calcium homeostasis in human vascular endothelial cellsMaud Kamal, Danielle Jacques, Ghassan Bkaily
Current Opinion in Oncology|July 2, 2019
Molecular screening programs in different countries: what we learned and perspectivesEdith Borcoman, Christophe Le Tourneau, Maud Kamal
Nature Medicine|May 1, 2019
Molecular profiling in precision medicine oncologyChristophe Le Tourneau, Edith Borcoman, Maud Kamal
Pharmacogenomics|June 9, 2017
The SHIVA01 trial: what have we learned?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Medecine Sciences : M/S|January 21, 2022
[Starting to integrate artificial intelligence for treatment decisions in oncology]Christophe Le Tourneau, Ivan Bièche, Maud Kamal
Personalized Medicine|September 28, 2018
Precision medicine in oncology: what is it exactly and where are we?Christophe Le Tourneau, Maud Kamal, Ivan Bièche
Pageof 12